Indication and Clinical use:
Enstilar® is indicated for the topical treatment of psoriasis vulgaris in adults for up to 4 weeks.
The use in pediatrics (<18 years of age) is not recommended as safety and efficacy have not been established in this population.
Relevant warnings and precautions:
For more information:
Please consult the Product Monograph at https://health-products.canada.ca/dpd-bdpp/index-eng.jsp for important information relating to adverse reactions, drug interactions, and dosing information, which have not been discussed in this piece. The Product Monograph is also available by calling LEO Pharma Medical Information at 1-800-263-4218.
© 2020 LEO Pharma Inc. All rights reserved.
® Registered trademark of LEO Pharma A/S used under license
and distributed by LEO Pharma Inc.